A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids
Clinical trial NCT00930163 · COMPLETED
Trial details
- NCT number
- NCT00930163
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2010-07-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.